VAERS Explorer
Back to explore

Report #2890302

Received Mar 23, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
Recovered
Not recovered
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER2UNK
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNK

Symptoms (4)

Herpes zosterNeuralgiaVaccination failureVisual impairment

Symptom narrative

Suspected vaccination failure; I had both shots and one year later got the shingles.; lost a lot of vision in my left eye; nerve pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a adult male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine and an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I had both shots and one year later got the shingles.), partial visual loss (Verbatim: lost a lot of vision in my left eye) and post herpetic neuralgia (Verbatim: nerve pain). The outcome of the vaccination failure was not reported and the outcome of the shingles, partial visual loss and post herpetic neuralgia were not resolved. It was unknown if the reporter considered the vaccination failure, shingles, partial visual loss and post herpetic neuralgia to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles, partial visual loss and post herpetic neuralgia to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK receipt date 16-MAR-2026 This case was reported by a consumer via interactive digital media. The patient had both shots and one year later got the shingles. It had lasted 2 years and 5 months now. The patient had lost a lot of vision in left eye and the nerve pain never eases. This case was considered as suspected vaccination failure since the details laboratory confirmation of shingles was not reported. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Vaccination failure, 1 year after vaccination with 1st dose of Shingles vaccine and on an unknown time after vaccination with 2nd dose of Shingles vaccine, in an adult male patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.